Shailender Bhatia

Fred Hutchinson Cancer Research Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (19)

Stefan Kasper

Professor of Medical Oncology

GERMANY

View details

Michi Shinohara

Associate Professor

University of Washington

UNITED STATES

View details

Lisa C Zaba

Stanford University School of Medicine

UNITED STATES

View details

Peter Goff

University of Washington

UNITED STATES

View details

Jacob Choi

Assistant Professor

Emory University

UNITED STATES

View details

Raphael Gottardo

University of Lausanne

SWITZERLAND

View details

Sylvia Lee

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Song Youn Park

Assistant Professor

University of Washington

UNITED STATES

View details

Tomoko Akaike

Assistant professor

University of Washington

UNITED STATES

View details

Kevin Chiu

Santa Clara University

UNITED STATES

View details

Ata Moshiri

Assistant Professor

NYU School of Medicine

UNITED STATES

View details

Aparna Hegde

The University of Alabama

UNITED STATES

View details

Evan Hall

Assistant Professor

University of Washington

UNITED STATES

View details

Funda Meric-Bernstam

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Shahneen Sandhu

AUSTRALIA

View details

Carolyn Shasha

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Richard K. Cheng

UNITED STATES

View details

Paul Nghiem

Professor

University of Washington

UNITED STATES

View details

Kimberly Smythe

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shailender Bhatia

Research Interests

Explore related searches

Contact this professor

Articles (17)

Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapy

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study

Increased risk of recurrence and disease-specific death following delayed post-operative radiation for Merkel cell carcinoma.

Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.

Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvec.

Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case–Control Study and Literature Review

Neoantigen-specific CD4<sup>+</sup> T cells in human melanoma have diverse differentiation states and correlate with CD8<sup>+</sup> T cell, macrophage, and B cell function.

Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

Real-world clinical outcomes with avelumab in patients with Merkel cell carcinoma treated in the USA: a multicenter chart review study

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinoma.

Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot study.

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study

Clitoral metastasis of vulvar melanoma treated with talimogene laherparepvec.

Harnessing Natural Killer Cells in Cancer Immunotherapy: A Review of Mechanisms and Novel Therapies.

Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma

How we treat Merkel cell carcinoma: within and beyond current guidelines.

Collaborators (19)

Stefan Kasper

Michi Shinohara

Lisa C Zaba

Peter Goff

Jacob Choi

Raphael Gottardo

Sylvia Lee

Song Youn Park

Tomoko Akaike

Kevin Chiu

Ata Moshiri

Aparna Hegde

Evan Hall

Funda Meric-Bernstam

Shahneen Sandhu

Carolyn Shasha

Richard K. Cheng

Paul Nghiem

Kimberly Smythe

Make your next move.